Hindustan Unilever Ltd Share Price

HUL Bets on New India, Markets Await Proof

(HUL) is revamping its growth playbook after two years of muted revenue performance. At its Capital Markets Day 2026, the company unveiled its “Winning in New India” strategy, targeting structural shifts in the FMCG sector and aiming for volume-led revenue expansion. Growth Drivers: HUL expects 40% of incremental growth from consumption and premiumization, another 40% from new user acquisition, and 20% from entering fresh categories. However, the company has not provided a timeline or quantified targets, leaving investors cautious about execution speed. Operational Initiatives: Over the past year, HUL has implemented five major steps: elevating brand desirability through its SASSY framework (science, aesthetics, sensorial, said-by-others, youthful), sharper resource allocation, accelerating growth pockets across geographies and channels, strengthening execution, and rewiring its operating model for agility. These measures have already lifted quarterly underlying sales growth from 3% in early FY26 to 10% in Q1FY27. Margins & Capex: The company widened its medium-term EBITDA margin guidance to 22–24%, supported by premiumization and cost savings. Capex intensity is set to rise to 3% of sales, with over 85% directed toward growth and efficiency initiatives. HUL expects its gross-margin-accretive portfolio to grow at 1.5x the pace of the rest. Investor Concerns: Despite operational improvements, investor sentiment remains subdued. The absence of double-digit EPS growth guidance and lack of clarity on timelines weigh on confidence. HUL’s stock trades at ~41x FY27 EPS estimates, near its 52-week low, with inflation and El Niño-related pressures adding risk. Analysts note that while beauty, wellbeing, and nutrition may offset competitive intensity in soaps and home care, proof of sustained execution is critical.

See More

Stocks to BUY, SELL or HOLD Today: Hindustan Unilever,

Stocks to BUY, SELL or HOLD Today, September 7: Indian equities are likely to witness a cautious start on Monday, with a slew of brokerage calls putting several stocks in focus. Brokerages remain bullish on Hindustan Unilever, with Nuvama, Jefferies, MOFSL and

Goldman Sachs retaining ‘BUY’ ratings, while Elara Capital reiterated ‘ACCUMULATE’. Fortis Healthcare and LG Electronics also received positive calls, while Goldman Sachs maintained ‘BUY’ ratings on ICICI Bank and TBO Tek. Goldman Sachs retained a ‘NEUTRAL’ stance on LTIMindtree, while HDFC Securities maintained a ‘REDUCE’ rating on Hindustan Unilever. Hindustan Unilever: Brokerages have retained their bullish stance on Hindustan Unilever (HUL). Nuvama has maintained a BUY rating on the stock with a target price (TP) of Rs 2,820. Jefferies has also retained its BUY rating, with a target price of Rs 2,450, against the earlier target of Rs 2,850, implying a 25 per cent upside.

See More

HUL GROWTH STRATEGY DRAWS POSITIVE, SHARES EDGE LOWER

Hindustan Unilever Ltd. (HUL) shares traded moderately lower on Monday after the FMCG major unveiled its new growth strategy at its Capital Markets Day. While analysts largely viewed the plan positively, some flagged concerns around higher investments and a wider operating margin range. HUL shares were down 0.55%. The decline came amid weakness in the broader market. The stock has fallen around 15% so far in 2026, significantly underperforming the Nifty 50, which has declined 8.6% over the same period. HUL's market capitalisation currently stands at just under ₹4.64 lakh crore. As part of its strategy, HUL plans to increase capital expenditure to around 3% of turnover, compared with approximately 2% over the past five years. The company intends to deploy the additional investment toward premiumisation, market development and emerging consumption opportunities. HUL expects productivity improvements and portfolio-mix initiatives to generate around 500 basis points of savings, which would help fund the higher investments. The company has set a medium-term EBITDA margin target of 22-24%. The FMCG major also plans to expand into high-growth categories through extensions of its existing brands, leveraging brands from parent company Unilever, as well as through bolt-on acquisitions. Management indicated that underlying sales growth has improved sequentially over the past four reporting periods, rising from 3% to 10%, signalling improving momentum across the business.

See More

HUL’s New India strategy could revive growth momentum

is sharpening its “Winning in New India” strategy, prompting brokerages to remain constructive despite the stock’s weak performance. HUL has declined around 15% in 2026, but Jefferies, Nomura and HSBC retain Buy ratings, with targets of ₹2,440–₹2,450, implying around 24–25% upside from Friday’s close. The strategy focuses on premiumisation, sharper consumer segmentation, stronger brand investments, quick-commerce expansion and allocating resources towards fewer, larger growth opportunities. HUL generated ₹63,800 crore turnover in FY26, with 21 brands crossing ₹1,000 crore in annual sales and more than 90% of turnover coming from categories where it holds the No. 1 position. Recent operating trends also provide some comfort. Q1 FY27 revenue grew 10% YoY, while underlying volume growth stood at around 5%. Management expects FY27 to be stronger than FY26, although it continues to guide for an EBITDA margin of 22.5–23.5% amid input-cost pressures. The key catalyst will be whether the new strategy can translate HUL’s extensive distribution and brand strength into sustained volume-led growth and margin recovery. However, competition, higher investments and commodity inflation remain key risks. Overall, HUL’s strategic reset and improving volume trajectory offer a potential recovery opportunity. Execution, volume growth and margin protection will determine whether the stock can deliver the expected rerating.

See More

HUL Steps Up Investment to Revive Volume Growth

is changing gears after a relatively muted two-year period, and what stands out to me is that management is not looking at cost cutting alone. The strategy is to generate savings and then put that money back behind brands, distribution, products and newer categories. The company plans to increase capex to around 3% of turnover from 2% earlier, with more than 75% of future spending directed towards growth and savings initiatives. HUL is also targeting around 500 basis points of “fuel for growth” through better margins, operating efficiencies and savings, which it intends to reinvest in the business. Its medium-term EBITDA margin target has been set at 22–24%, compared with 23.6% in FY26. For me, the more interesting part is where HUL expects future growth to come from. Management expects increasing consumption and premiumisation to contribute about 40% each to incremental turnover, while entry into new spaces could contribute another 20%. Beauty, wellbeing, functional nutrition, premium products and convenience categories are among the areas being targeted. This tells me HUL is trying to balance two things: protect profitability while spending more aggressively to restart volume-led growth. The key thing I would track from here is whether higher investments actually translate into stronger volumes and market-share gains rather than only supporting margins. Learning Outcome: Cost savings become more valuable when a company reinvests them productively. Investors should track whether higher capex and brand spending eventually produce volume growth, market-share gains and sustainable profitability.

See More